BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Roberts DR, Chatterjee AR. The Critical Need for Pediatric and Juvenile Animal Research Addressing Gadolinium Retention in the Developing Body. Invest Radiol 2019;54:72-5. [PMID: 30273280 DOI: 10.1097/RLI.0000000000000516] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Ozturk K, Nascene D. Susceptibility-Weighted Imaging of the Pediatric Brain after Repeat Doses of Gadolinium-Based Contrast Agent. AJNR Am J Neuroradiol 2021;42:1136-43. [PMID: 33888459 DOI: 10.3174/ajnr.A7143] [Reference Citation Analysis]
2 Ozturk K, Nascene D. Effect of at Least 10 Serial Gadobutrol Administrations on Brain Signal Intensity Ratios on T1-Weighted MRI in Children: A Matched Case-Control Study. AJR Am J Roentgenol 2021;217:753-60. [PMID: 33112200 DOI: 10.2214/AJR.20.24536] [Reference Citation Analysis]
3 Ozturk K, Nascene D. Dentate nucleus signal intensity changes on T1-weighted MRI after repeated administrations of linear and macrocyclic gadolinium-based contrast agents: a pediatric intraindividual case-control study. Acta Radiol 2021;:2841851211018809. [PMID: 34018821 DOI: 10.1177/02841851211018809] [Reference Citation Analysis]
4 Kanal E, Patton TJ, Krefting I, Wang C. Nephrogenic Systemic Fibrosis Risk Assessment and Skin Biopsy Quantification in Patients with Renal Disease following Gadobenate Contrast Administration. AJNR Am J Neuroradiol 2020;41:393-9. [PMID: 32115422 DOI: 10.3174/ajnr.A6448] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]